FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1350-1351 November 16, 1995 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Expert panels in the United States and Europe have reinforced guidelines on lowering cholesterol as one of the fundamental preventive measures to reduce mortality from coronary heart disease.^1,2 Last year the report of the Scandinavian Simvastatin Survival Study strengthened the evidence on which the guidelines were based, demonstrating a survival benefit from lowering cholesterol with simvastatin in patients with coronary disease.³ One remaining question has been whether aggressive cholesterol lowering in persons without overt coronary heart disease will result in similar benefits, without increasing the risk of noncardiac mortality. Another problem has been to find effective methods for lowering cholesterol . . . [Full Text of this Article]

References

Related Letters:

Prevention of Coronary Heart Disease with Pravastatin
Rogers S., Samani N. J., de Bono D. P., Davis D. R., Shepherd J., Cobbe S. M., Ford I., The West of Scotland Coronary Prevention Study Group , Pedersen T. R.
Extract | Full Text  
N Engl J Med 1996; 334:1333-1335, May 16, 1996. Correspondence

This article has been cited by other articles:

• Brewer, H. B. Jr. (2004). High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease. Arterioscler. Thromb. Vasc. Bio. 24: 387-391 [Full Text]  
• Sanada, M., Higashi, Y., Nakagawa, K., Tsuda, M., Kodama, I., Kimura, M., Chayama, K., Ohama, K. (2002). Hormone Replacement Effects on Endothelial Function Measured in the Forearm Resistance Artery in Normocholesterolemic and Hypercholesterolemic Postmenopausal Women. J. Clin. Endocrinol. Metab. 87: 4634-4641 [Abstract] [Full Text]  
• Kishore, G. M., Shewmaker, C. (1999). Biotechnology: Enhancing human nutrition in developing and developed worlds. Proc. Natl. Acad. Sci. USA 96: 5968-5972 [Abstract] [Full Text]  
• John, S., Schlaich, M., Langenfeld, M., Weihprecht, H., Schmitz, G., Weidinger, G., Schmieder, R. E. (1998). Increased Bioavailability of Nitric Oxide After Lipid-Lowering Therapy in Hypercholesterolemic Patients : A Randomized, Placebo-Controlled, Double-blind Study. Circulation 98: 211-216 [Abstract] [Full Text]  
• Rogers, S., Samani, N. J., de Bono, D. P., Davis, D. R., Shepherd, J., Cobbe, S. M., Ford, I., The West of Scotland Coronary Prevention Study Gro, , Pedersen, T. R. (1996). Prevention of Coronary Heart Disease with Pravastatin. NEJM 334: 1333-1335 [Full Text]  
• Corson, J. D., Mohan, C. R., Hoballah, J. J., Sharp, W. J., Kresowik, T. F. (1996). Atherosclerosis and Risk Factor Modification: Does It Really Make a Difference?. PERSPECT VASC SURG ENDOVASC THER 9: 75-94